A prospective, open-label, observational cohort study of continuous subcutaneous apomorphine infusion in patients with Parkinson's disease
Latest Information Update: 22 Oct 2020
At a glance
- Drugs Apomorphine (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- Acronyms OPTIPUMP
- 22 Oct 2020 New trial record
- 16 Sep 2020 Results (n=89) assessing monocentric experience of apomorphine pump follow up on PD patients, presented at the 24th International Congress of Parkinson's Disease and Movement Disorders